Pre-treatment prostate MRI predicts recurrence and survival after surgery. Discover how imaging improves risk assessment.
International experts have recommended quick and targeted MRI scans for prostate cancer screening. Some 21 urologists, radiologists and pathologists from Europe and the US agreed an "expert consensus ...
An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...
A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...
Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...
The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...
A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. The addition of piflufolastat F18 (18 F-DCFPyL) prostate-specific membrane antigen ...
Lucida Medical has raised £8.7m to power its ‘same-day’ cancer diagnosis. IW Capital has invested in the Cambridge healthtech ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ('Profound” or the 'Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results